GT-032 Belapectin

Belapectin · Galectin Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GT-032 Belapectin, covering 2026-07-14 to 2026-07-14. Get the full timeline:

Most recent: Clinical Trial Results: GT-032 Belapectin Hepatic Impairment [Phase 1]